Evidence map›Paper›PMID 41782129›Full record

Trial reportBMC complementary medicine and therapies2026

Clinical evaluation of the efficacy and safety of nasturtium herb and horseradish root versus placebo in the continuous prophylaxis of recurrent uncomplicated cystitis: a double-blind randomised clinical trial.

Uwe Albrecht, Gregor Schmitz, Ulrich Stefenelli, Nina Kassner, Meinolf Wonnemann, Lukas Schablauer, Niklas Lonnemann, Lisa Felix, Ruth Kirschner-Hermanns

Abstract readRandomized Controlled TrialMulticenter StudyClinical Trial, Phase III
In one paragraph

Trial report in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Uwe AlbrechtMediconomics GmbH, Misburger Straße 81B, Hanover, 30625, Germany. albrecht@mediconomics.com.
Gregor SchmitzJoint general practice, Balve, Germany.
Ulrich StefenelliData Scientist Würzburg, Würzburg, Germany.
Nina KassnerRepha GmbH Biologische Arzneimittel, Langenhagen, Germany.
Meinolf WonnemannRepha GmbH Biologische Arzneimittel, Langenhagen, Germany.
Lukas SchablauerMediconomics GmbH, Misburger Straße 81B, Hanover, 30625, Germany.
Niklas LonnemannMediconomics GmbH, Misburger Straße 81B, Hanover, 30625, Germany.
Lisa FelixMediconomics GmbH, Misburger Straße 81B, Hanover, 30625, Germany.
Ruth Kirschner-HermannsNeurological Rehabilitation Centre Godeshöhe, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThis study aimed to demonstrate the efficacy and safety of a herbal combination drug of nasturtium herb and horseradish root in the continuous prophylaxis of recurring uncomplicated cystitis.

methodsThe clinical trial was conducted as a phase III, two-armed, placebo-controlled, randomised, double-blind, prospective, and multi-center study, which followed a parallel-group design in Germany. Data were collected in a multicenter setup in Germany. Patients of either sex aged ≥ 18 years with recurring uncomplicated cystitis were considered for the study. Interventions were Nasturtium herb and horseradish root prophylaxis versus placebo. The primary outcome measure was the rate of first recurrent urinary tract infection (rUTI) observed during six months of recurrence prophylaxis in the herbal and the placebo group from day 0 to day 180. Additional efficacy outcome measures included: recurrence rates at scheduled visits during the course of recurrence prophylaxis; recurrence rates during three- and six-month follow-up and Investigator’s assessment of efficacy at completion of recurrence prophylaxis. Safety evaluation included type, frequency, and severity of reported adverse events.

resultsA total of 224 patients were enrolled, of which 217 women were included in the full analysis set. Patients were randomised to treatment with either nasturtium herb and horseradish root (N = 110) or placebo (N = 107). The cumulative recurrence rate increased for the placebo group to approximately 40% by day 90 and 48% by day 180, while the nasturtium herb and horseradish root group had lower rates of 26% and 36%, respectively. The overall risk of rUTI was reduced by 36% (hazard ratio [HR] 0.64, 95% confidence interval [CI] 0.42–0.97, p = 0.0327) in the treatment group. This effect remained consistent (although statistically insignificant) during the follow-up period up to 360 days. There were no significant differences between groups, for any of the reported adverse effects.

conclusionThe results of this study indicate that nasturtium herb and horseradish root may be an effective, safe prophylactic treatment for female patients suffering from rUTIs.

trial registrationThis trial was registered with EudraCT under the number: EudraCT 2013-004653-25. The study was approved on 2nd of May 2014 and the first participant was enrolled on 9th of May 2014.

Indexed as

CystitisNasturtiumPlant ExtractsUrinary Tract InfectionsAdultDouble-Blind MethodFemaleGermanyHumansMaleMiddle AgedPhytotherapyPlant RootsProspective StudiesRecurrenceSecondary PreventionPlant ExtractsAntimicrobial resistanceCystitis prophylaxisHerbal medicineHorseradish rootIsothiocyanatesNasturtium herbRecurrent urinary tract infections (rUTIs)

Identifiers

PMID41782129
PMCPMC13063873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.